Mixed Results for Factor Xa Drug in Medical Ward

ACC 2011 — NEW ORLEANS -- An extended course of the novel anticoagulant rivaroxaban (Xarelto) may prevent venous thromboembolism better than a standard course of enoxaparin (Lovenox) in acutely-ill medical patients, but at the cost of more bleeding, researchers found.


< Back to Listings